Kanomata Kazuhiro, Kokabu Shoichiro, Nojima Junya, Fukuda Toru, Katagiri Takenobu
Division of Pathophysiology, Research Center for Genomic Medicine, Saitama Medical University, 1397-1 Yamane, Hidaka-shi, Saitama 350-1241, Japan.
Genes Cells. 2009 Jun;14(6):695-702. doi: 10.1111/j.1365-2443.2009.01302.x. Epub 2009 May 5.
Bone morphogenetic proteins (BMPs) induce osteoblastic differentiation of myoblasts via binding to cell surface receptors. Repulsive guidance molecules (RGMs) have been identified as BMP co-receptors. We report here that DRAGON/RGMb, a member of the RGM family, suppressed BMP signaling in C2C12 myoblasts via a novel mechanism. All RGMs were expressed in C2C12 cells that were differentiated into myocytes and osteoblastic cells, but RGMc was not detected in immature cells. In C2C12 cells, only DRAGON suppressed ALP and Id1 promoter activities induced by BMP-4 or by constitutively activated BMP type I receptors. This inhibition by DRAGON was dependent on the secretory form of the von Willbrand factor type D domain. DRAGON even suppressed BMP signaling induced by constitutively activated Smad1. Over-expression of neogenin did not alter the inhibitory capacity of DRAGON. Taken together, these findings indicate that DRAGON may be an inhibitor of BMP signaling in C2C12 myoblasts. We also suggest that a novel molecule(s) expressed on the cell membrane may mediate the signal transduction of DRAGON in order to suppress BMP signaling in C2C12 myoblasts.
骨形态发生蛋白(BMPs)通过与细胞表面受体结合诱导成肌细胞向成骨细胞分化。排斥性导向分子(RGMs)已被鉴定为BMP共受体。我们在此报告,RGM家族成员DRAGON/RGMb通过一种新机制抑制C2C12成肌细胞中的BMP信号传导。所有RGMs在分化为肌细胞和成骨细胞的C2C12细胞中均有表达,但在未成熟细胞中未检测到RGMc。在C2C12细胞中,只有DRAGON抑制由BMP-4或组成型激活的BMP I型受体诱导的碱性磷酸酶(ALP)和Id1启动子活性。DRAGON的这种抑制作用依赖于血管性血友病因子D结构域的分泌形式。DRAGON甚至抑制由组成型激活的Smad1诱导的BMP信号传导。新生蛋白的过表达并未改变DRAGON的抑制能力。综上所述,这些发现表明DRAGON可能是C2C12成肌细胞中BMP信号传导的抑制剂。我们还提出,细胞膜上表达的一种新分子可能介导DRAGON的信号转导,从而抑制C2C12成肌细胞中的BMP信号传导。